Drug Profile
Research programme: neurodegenerative disorders diagnostic imaging - Piramal Healthcare
Alternative Names: 18F-DeprenylLatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Bayer HealthCare Pharmaceuticals
- Class Radiopharmaceutical diagnostics
- Mechanism of Action Positron-emission tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Neurodegenerative disorders
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Neurodegenerative-disorders(Diagnosis) in Germany (Parenteral)
- 13 Nov 2014 Preclinical development is ongoing in Germany
- 13 Nov 2014 Research programme: neurodegenerative disorders diagnostic imaging - Piramal Healthcare is available for licensing as of 13 Nov 2014. http://piramal.com/piramal-enterprises/piramal-capital